Octave develops blood-based biomarker tests that illuminate the path forward for patients with neurodegenerative diseases, starting with multiple sclerosis and expanding into other conditions like Parkinson's and Alzheimer's
Octave develops blood-based biomarker tests that illuminate the path forward for patients with neurodegenerative diseases, starting with multiple sclerosis and expanding into other conditions like Parkinson's and Alzheimer's.